The Psychopharmacology of Psychedelics

Share

Program Content

Activities

  • Psychopharm of psychedelics
    The Psychopharmacology of Psychedelics
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 29, 2023

Faculty

cover img faculity

Michael Alpert, MD

Sub-investigator, Educator, Psychiatrist
MAPS Public Benefit Corporation
Instructor
Department of Psychiatry
Beth Israel Deaconess Medical Center – Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AbbVie Inc.; Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc; and an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Neurocrine Biosciences, Inc.

Opioid Analgesic REMS Program Companies